Aptevo Therapeutics (APVO) SVP SoYoung Kwon converts 638 RSUs to stock
Rhea-AI Filing Summary
Aptevo Therapeutics Inc. reported that officer SoYoung Kwon (SVP, GC, BD & Corp Affairs) exercised 638 Restricted Stock Units into 638 shares of common stock on August 6, 2026. The RSUs converted to common stock on a one-for-one basis, leaving 0 RSUs from this grant and resulting in 638 common shares held directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 638 shares
Net Buy
2 txns
Insider
Kwon SoYoung
Role
SVP, GC, BD & Corp Affairs
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit F1, F2 | 638 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 638 | -- | -- |
Holdings After Transaction:
Restricted Stock Unit — 0 shares (Direct);
Common Stock — 638 shares (Direct)
Footnotes (2)
- F1. Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
- F2. On August 6, 2025, the reporting person was granted 11,500 (638 post-split) RSUs, vesting on the first anniversary of the date of grant.
Key Figures
RSUs exercised: 638 RSUs
Common shares received: 638 shares
RSUs remaining from this grant: 0 RSUs
+2 more
5 metrics
RSUs exercised
638 RSUs
Restricted Stock Units converted to common stock on August 6, 2026
Common shares received
638 shares
Shares of Aptevo common stock received upon RSU conversion
RSUs remaining from this grant
0 RSUs
Total RSUs following the reported derivative transaction
Common shares held after transaction
638 shares
Direct ownership position after the August 6, 2026 transaction
Original RSU grant size
11,500 RSUs
RSUs granted on August 6, 2025 (638 post-split) vesting after one year
Key Terms
Restricted Stock Unit, one-for-one basis, post-split
3 terms
Restricted Stock Unit financial
"The security title reported is "Restricted Stock Unit"."
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
one-for-one basis financial
"RSUs convert into common stock on a one-for-one basis."
post-split financial
"The reporting person was granted 11,500 (638 post-split) RSUs."
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did Aptevo Therapeutics (APVO) report for SoYoung Kwon?
Aptevo reported that SoYoung Kwon exercised 638 Restricted Stock Units into 638 shares of common stock on August 6, 2026, as part of previously granted equity compensation.
How many Aptevo Therapeutics (APVO) RSUs did SoYoung Kwon convert and what did she receive?
She converted 638 RSUs, which turned into 638 shares of Aptevo common stock on a one-for-one basis, reflecting the standard RSU-to-share conversion ratio described in the filing footnotes.
What are SoYoung Kwon’s Aptevo (APVO) holdings after the August 6, 2026 transaction?
Following the transaction, SoYoung Kwon directly holds 638 shares of Aptevo common stock. The specific RSU grant involved in this transaction shows 0 RSUs remaining after conversion.
What was the origin of the 638 RSUs reported for Aptevo Therapeutics (APVO)?
According to the footnotes, on August 6, 2025, SoYoung Kwon was granted 11,500 RSUs (638 post-split), which were scheduled to vest on the first anniversary of the grant date and then convert into common stock.
Was the Aptevo (APVO) Form 4 transaction under a Rule 10b5-1 trading plan?
The filing’s Rule 10b5-1 checkbox is not marked as affirmed, and the footnotes do not reference a trading plan, so the reported RSU conversion does not indicate 10b5-1 plan status.